Page 83 - NobleCon20-Book-Project
P. 83
GoHealth, Inc.
SELECTED FINANCIAL ITEMS GOCO
(in millions of USD)
CQ4 '23 CQ1 '24 CQ2 '24 CQ3 '24 LTM
Income Statement Key Items
Total Revenue 276.70 185.60 105.87 118.29 686.46
Gross Profit 235.61 147.59 85.19 98.61 567.00
Gross Margin 85% 80% 80% 83% 83%
EBIT 25.06 (4.03) (40.61) (41.77) (61.35)
EBIT Margin 9% -2% -38% -35% -9%
Net Income to Common Shareholders (2.29) (21.35) (59.31) 15.37 (67.59)
Net Margin -1% -12% -56% 13% -10%
Balance Sheet Key Items
Total Assets 1,499.57 1,395.26 1,257.08 1,341.15 1,341.15
Cash & Short Term Investments 90.81 97.82 14.12 35.53 35.53
% of Assets 6% 7% 1% 3% 3%
Current Assets -Total 476.44 397.10 301.17 334.04 334.04
% of Assets 32% 28% 24% 25% 25%
Total Liabilities 1,044.62 959.43 878.18 943.87 943.87
% of Assets 70% 69% 70% 70% 70%
Current Liabilities - Total 370.01 300.00 234.04 281.97 281.97
% of Assets 25% 22% 19% 21% 21%
Long Term Debt 422.71 410.32 413.33 416.33 416.33
% of Assets 28% 29% 33% 31% 31%
Total Equity 454.96 435.83 378.90 397.28 397.28
% of Assets 30% 31% 30% 30% 30%
Cash Flow Statement Key Items
Net Cash Flow - Operating Activities 71.30 12.51 (36.50) (12.23) 35.09
Net Cash Flow - Investing (5.65) (4.56) (2.70) 13.28 0.38
Net Cash Flow - Financing (1.09) (0.94) (44.45) 20.33 (26.15)
Source: Capital IQ
PRICE / VOLUME
Source: Channelchek/QuoteMedia
Noble Capital Markets' Twentieth Annual Small & Microcap Investor Conference